These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9392143)

  • 21. Evolution of new hormone function: loss and gain of a receptor.
    Irwin DM; Wong K
    J Hered; 2005; 96(3):205-11. PubMed ID: 15653559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon receptors.
    Authier F; Desbuquois B
    Cell Mol Life Sci; 2008 Jun; 65(12):1880-99. PubMed ID: 18292967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of the glucagon receptor gene to human chromosome band 17q25.
    Menzel S; Stoffel M; Espinosa R; Fernald AA; Le Beau MM; Bell GI
    Genomics; 1994 Mar; 20(2):327-8. PubMed ID: 8020989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization and regulation of glucagon receptors in the chick eye and preproglucagon and glucagon receptor expression in the mouse eye.
    Feldkaemper MP; Burkhardt E; Schaeffel F
    Exp Eye Res; 2004 Sep; 79(3):321-9. PubMed ID: 15336494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular cloning and functional expression of glucagon receptors in the liver, the heart and various other tissues].
    Christophe J
    Bull Mem Acad R Med Belg; 1994; 149(5-7):271-7; discussion 277-8. PubMed ID: 7795550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and characterization of the glucagon receptor from cynomologous monkey.
    McNally T; Grihalde ND; Pederson TM; Ogiela CA; Djuric SW; Collins CA; Lin CW; Reilly RM
    Peptides; 2004 Jul; 25(7):1171-8. PubMed ID: 15245877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties.
    Madsen P; Kodra JT; Behrens C; Nishimura E; Jeppesen CB; Pridal L; Andersen B; Knudsen LB; Valcarce-Aspegren C; Guldbrandt M; Christensen IT; Jørgensen AS; Ynddal L; Brand CL; Bagger MA; Lau J
    J Med Chem; 2009 May; 52(9):2989-3000. PubMed ID: 19385613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New beta-alanine derivatives are orally available glucagon receptor antagonists.
    Lau J; Behrens C; Sidelmann UG; Knudsen LB; Lundt B; Sams C; Ynddal L; Brand CL; Pridal L; Ling A; Kiel D; Plewe M; Shi S; Madsen P
    J Med Chem; 2007 Jan; 50(1):113-28. PubMed ID: 17201415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of glucagon receptor expression.
    Nishimura E; Abrahamsen N; Hansen LH; Lundgren K; Madsen O
    Acta Physiol Scand; 1996 Jul; 157(3):329-32. PubMed ID: 8830887
    [No Abstract]   [Full Text] [Related]  

  • 30. Gly40Ser mutation of glucagon receptor gene and essential hypertension in Japanese.
    Fujisawa T; Ikegami H; Babaya N; Ogihara T
    Hypertension; 1996 Dec; 28(6):1100. PubMed ID: 8952603
    [No Abstract]   [Full Text] [Related]  

  • 31. [Glucagon receptor gene].
    Inoue H; Oka Y
    Nihon Rinsho; 1997 Oct; 55 Suppl():429-31. PubMed ID: 9392143
    [No Abstract]   [Full Text] [Related]  

  • 32. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus.
    Hager J; Hansen L; Vaisse C; Vionnet N; Philippi A; Poller W; Velho G; Carcassi C; Contu L; Julier C
    Nat Genet; 1995 Mar; 9(3):299-304. PubMed ID: 7773293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism of the glucagon receptor gene and non-insulin-dependent diabetes mellitus in the Russian population.
    Babadjanova G; Reincke M; Mora P; Chuchalin A; Allolio B
    Exp Clin Endocrinol Diabetes; 1997; 105(4):225-6. PubMed ID: 9285210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gly40Ser mutation of glucagon receptor gene and NIDDM in Han nationality].
    Deng H; Tang WL; Pan Q
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):291-3. PubMed ID: 12536714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes.
    Ali S; Drucker DJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E415-21. PubMed ID: 19116373
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.